x

Chromocell Therapeutics Corp (NYSE:CHRO)

Health Care/Life Sciences • Pharmaceuticals
CIK 1919246
Company

Chromocell Therapeutics Corp. is a clinical-stage biotech company that engages in the development and commercialization of new therapeutics to alleviate pain. Its clinical focus is to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. The company was founded on March 19, 2021 and is headquartered in Freehold, NJ.

Address
4400 Route 9 South
Suite 1000
07728, New Jersey 08906
Employees
6
Stock Info
Close
$3.32
Day Range
3.29 - 3.63
52 Week Range
3.16 - 6.00
Average volume
41.49K
Short Interest
111 (02/29/24)
% of Float Shorted
0.01%
Market Cap
$20.42M
Revenue
N/A
Net Income
-$2.46M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$0.71
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Vice Chairman & Chief Strategy Officer
Christian Kopfli LLD
Director
Ezra M Friedberg
Chairman
Todd C Davis MBA
SEC filings
DateFormEvent
13 Aug, 2024 424B3
13 Aug, 2024 10-Q
13 Aug, 2024 424B3
7 Aug, 2024 8-K
6 Aug, 2024 D
6 Aug, 2024 D
6 Aug, 2024 424B3
6 Aug, 2024 EFFECT
2 Aug, 2024 UPLOAD
2 Aug, 2024 CORRESP
29 Jul, 2024 424B3
29 Jul, 2024 424B3
29 Jul, 2024 S-1
29 Jul, 2024 8-K
2 Jul, 2024 3/A
2 Jul, 2024 4
18 Jun, 2024 4
18 Jun, 2024 4
18 Jun, 2024 4
18 Jun, 2024 4
18 Jun, 2024 4
18 Jun, 2024 4
18 Jun, 2024 4/A
15 May, 2024 10-Q
15 May, 2024 424B3
15 May, 2024 424B3
17 Apr, 2024 424B3
17 Apr, 2024 424B3
17 Apr, 2024 POS EX
16 Apr, 2024 10-K
15 Apr, 2024 S-8
9 Apr, 2024 8-K
1 Apr, 2024 NT 10-K
21 Mar, 2024 8-K
18 Mar, 2024 8-K CEO Change
13 Mar, 2024 8-K
12 Mar, 2024 4/A
4 Mar, 2024 SC 13G
1 Mar, 2024 SC 13G
1 Mar, 2024 SC 13G
1 Mar, 2024 SC 13G
1 Mar, 2024 SC 13G
1 Mar, 2024 SC 13G
26 Feb, 2024 SC 13D
23 Feb, 2024 4
23 Feb, 2024 4
23 Feb, 2024 4
22 Feb, 2024 8-K
20 Feb, 2024 SEC STAFF
20 Feb, 2024 424B4 IPO completed
20 Feb, 2024 424B4
16 Feb, 2024 POS EX
15 Feb, 2024 CERT
15 Feb, 2024 3
15 Feb, 2024 3
15 Feb, 2024 3
15 Feb, 2024 3
15 Feb, 2024 3
15 Feb, 2024 3
15 Feb, 2024 8-A12B
15 Feb, 2024 3
15 Feb, 2024 3
15 Feb, 2024 3
15 Feb, 2024 3
14 Feb, 2024 S-1/A
14 Feb, 2024 EFFECT
12 Feb, 2024 S-1/A
12 Feb, 2024 FWP
12 Feb, 2024 CORRESP
12 Feb, 2024 CORRESP
7 Feb, 2024 FWP
7 Feb, 2024 S-1/A
31 Jan, 2024 FWP
30 Jan, 2024 S-1/A
30 Jan, 2024 CORRESP
25 Jan, 2024 UPLOAD
23 Jan, 2024 SEC STAFF
16 Jan, 2024 S-1/A
8 Nov, 2023 FWP
8 Nov, 2023 S-1/A
25 Oct, 2023 S-1/A
24 Oct, 2023 UPLOAD
16 Oct, 2023 FWP
16 Oct, 2023 S-1/A
13 Oct, 2023 CORRESP
12 Sep, 2023 UPLOAD
1 Sep, 2023 S-1/A
1 Sep, 2023 CORRESP
24 Jul, 2023 CORRESP
20 Jul, 2023 S-1/A
10 Jul, 2023 UPLOAD
30 Jun, 2023 CORRESP
30 Jun, 2023 S-1/A
19 May, 2023 UPLOAD
1 May, 2023 S-1/A
1 May, 2023 CORRESP
23 Jan, 2023 UPLOAD
20 Jan, 2023 S-1/A
11 Jan, 2023 CORRESP
11 Jan, 2023 S-1
31 Oct, 2022 UPLOAD
17 Oct, 2022 DRS/A
14 Oct, 2022 DRSLTR
3 Oct, 2022 UPLOAD
6 Sep, 2022 DRS
Last update:2024-03-12 12:02:07.407338
Chromocell Therapeutics Corp by TradingView

Sign Up to Subscribe